Azenta, Inc. announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in life scienc…
Cellares, the first Integrated Development and Manufacturing Organizatio, announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company…
Nanologica AB has entered into an agreement and completed the acquisition of all shares in Ardena Södertälje AB (“Syntagon”) from Ardena Sweden. The purchase price amounts to approximately SEK 8.6 million and will be paid in the form of newly issued shares in Nanologica. Syntagon is a Contract Development and Manufact…
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Compa…
OXB , a global quality and innovation-led cell and gene therapy CDMO, announces it has expanded its strategic partnership with Bristol Myers Squibb , signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS' CAR-T programmes. This expanded partnership builds on the …
Jumo Health, a Patient Experience Organization, today announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM™, Jumo Health's readiness-based clinical trial recruitment, enrollment, and retention system. PRISM was created to address a persistent …
SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global licensing agreement with Genentech, a member of the Roche Group, to advance one of its RNAi programs based on its proprietary RNAi platform. Under the agreement, SanegeneBio grants Genentech exclusive worldw…
Illumina, Inc. announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The highly complementary proteomics capabilities expand Illumina's multiomics portfolio, strengthening customer access to proteomic insights at scale to help drive faster drug discovery and posit…
Spring Health, a leading global mental health platform for employers and health plans, announced it has entered into an agreement to acquire Alma, a membership-based platform that helps independent mental health clinicians accept insurance and build thriving private practices. This acquisition unites two category lea…
WuXi Biologics , a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and Sinorda Biomedicine today jointly announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for the potential treatment of inflammatory bowel disease (IB…
Page 20 of 40